CClinicalTrials.gg
CompletedNCT06522841Updated Jul 26, 2024

16SRDNA Sequencing of 30 Samples of Human Oral Microbial Samples by Tianjin Medical University

An observational study in Oral Microbiome, Sampling Methods and Epidemiological Studies, sponsored by Tianjin Medical University. Completed at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by Tianjin Medical University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Study Objective:

To explore suitable sampling sites and methods for oral epidemiological surveys in large populations, we aim to compare the distribution of the oral core microbiome at different sites and using different sampling methods in a small sample of healthy individuals.

Main Question:

What is the distribution of the oral core microbiome at different sampling sites and using different sampling methods in orally healthy individuals?

Study Design:

Participants will be randomly selected from a population of orally healthy individuals. After explaining the study to the participants and obtaining informed consent, they will complete a consent form and be informed of the precautions. Samples will be collected using cotton swabs and curettes from the buccal surface of the lower right first molar and using cotton swabs from the left and right buccal mucosa. The samples will be placed in pre-numbered test tubes and sent to the laboratory for microbiome analysis.

02

Conditions studied

  • Oral Microbiome
  • Sampling Methods
  • Epidemiological Studies
03

In context

Lead sponsor

Tianjin Medical University is the lead sponsor of 46 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

According to WHO-related standards, we have selected adults who are orally healthy, free from systemic diseases, and non-smokers.

Inclusion criteria

  • (1) People who had no oral diseases particularly caries, periodontitis, and oral mucosal diseases. (2) Teeth without previous restorations.

Exclusion criteria

Exclusion Criteria:

  • (1) People who are pregnant. (2) People who suffer from severe systematic diseases, such as diabetes, immune system diseases, and genetic diseases. (3) People who have taken antibiotics within two weeks before sampling.(4) People who have had or currently receiving radiotherapy or chemotherapy. (5) People with complete or incomplete absence of dentition. (6) Individuals who smoke or have smoked within the past six months
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. 16SRDNA sequencing of 30 samples of human oral microbial samples by Tianjin Medical University

    Four sites were assessed: the buccal mucosa on both sides and the buccal surfaces of the left and right mandibular first molars. Two sampling methods, swab and curette, were used to collect bacterial communities from healthy individuals. Specifically, buccal mucosa samples (n=10) and tooth surface samples (n=20) were analyzed using 16S rDNA gene sequencing. Bacterial signals were detected through fluorescence in situ hybridization (FISH), targeting the bacterial 16S rDNA gene. Metastats analysis and Wilcoxon test were used.

    Time frame: 2021.07 - 2021.12 Finalize research topic. 2021.12 - 2022.06 Complete bibliometric analysis. 2022.06 - 2022.12 Acquire data for analysis. 2022.12 - 2023.06 Obtain analysis results. 2023.06 - 2024.01 Complete and submit the thesis.

07

Study locations

1 site
  • Tianjin Medical University School of Stomatology
    Tianjin, Tianjin 300070, China
08

References and documents

Individual participant data

Plan to share: Undecided — Objective: Our goal is to facilitate the advancement of scientific research by sharing individual participant data (IPD) from our study on the microbial community diversity in various regions of the healthy oral cavity. This sharing plan is designed to ensure that data is accessible to researchers while protecting the privacy and confidentiality of study participants. Data to be Shared: The IPD to be shared includes: 1. Demographic Information: * Age * Gender 2. Microbial Data: * Microbiome sequencing data (raw and processed sequences) * Operational Taxonomic Units (OTUs) and species-level identification 3. Sampling and Processing Details: * Method of sample collection (swab vs. scraper)

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06522841
Lead sponsor
Tianjin Medical University
Responsible party
Yuchang Liu (Department of Endodontics and Laboratory for Dental Stem Cells and Endocrine Immunology, Tianjin Medical University School of Stomatology, Tianjin, China., Tianjin Medical University) — Principal investigator
First posted
Jul 26, 2024
Start date
Sep 1, 2021
Primary completion
Dec 2, 2021
Completion
Jun 1, 2024
Last update
Jul 26, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion